CELC Since 2017 Annualized Return and Average Annual Return

CELC Average Annual Return Chart Since 2017
Growth of $10,000.00
Without Dividends Reinvested Into CELC

Also see:
• CELC stock yearly return 2018
• CELC stock yearly return 2019
• CELC stock yearly return 2020
• CELC stock yearly return 2021
• CELC stock yearly return 2022
• CELC stock yearly return 2023
• CELC stock yearly return 2024
• CELC stock yearly return 2025
• CELC YTD return
Average Annual Return Benchmarks
Compare CELC average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
CELC Share Performance
CELC Average Annual Return Table Since 2017
Start date: 09/21/2017
End date: 06/10/2026
Start price/share: $13.41
End price/share: $88.24
Dividends collected/share: $0.00
Total return: 558.02%
CELC Average Annual Return: 24.11%
Starting investment: $10,000.00
Ending investment: $65,811.76
Years: 8.72


CELC average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Celcuity Inc
Celcuity Inc. is a clinical-stage biotechnology company developing targeted therapies for solid tumors. Its lead candidate, gedatolisib, is a small molecule inhibitor targeting all Class I PI3K isoforms and mTOR sub-complexes (mTORC1 and mTORC2). Initial clinical programs focus on treating hormone receptor positive (HR+), HER2-negative (HER2-), advanced or metastatic breast cancer, and metastatic castration-resistant prostate cancer. The VIKTORIA-1 trial evaluates gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- advanced breast cancer. The CELsignia diagnostic platform analyzes live tumor cells to identify new cancer patient groups. The CELC average annual return since 2017 is shown above.

The Average Annual Return on the CELC average annual return since 2017 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CELC average annual return since 2017 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CELC average annual return calculation with any dividends reinvested as applicable (on ex-dates).
CELC Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree CELC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Celcuity (CELC) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CELU Average Annual Return
CELZ Average Annual Return
CERS Average Annual Return
CGEM Average Annual Return
CGEN Average Annual Return
CGON Average Annual Return
CGTX Average Annual Return
CHE Average Annual Return
CHRS Average Annual Return
CI Average Annual Return
More Healthcare companies »
 

CELC Average Annual Return Since 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.